Skip to main content

Advertisement

Table 1 Comparison between the characteristics of male and female HCCs

From: Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?

Clinical variables Female (n = 118) Male (n = 398) P
Age 57.7 ± 14.3 56.2 ± 13.8 0.310
Anti-HCV positive, n (%) 44 (37.3%) 91 (22.9%) 0.002
HBsAg positive, n (%) 70 (59.3%) 289 (72.6%) 0.006
Liver cirrhosis, n (%) 67 (56.8%) 230 (57.8%) 0.846
Non-cirrhosis, ALT <2×ULNa, n (%) 43 (36.4%) 125 (31.4%) 0.361
Non-cirrhosis, ALT >2×ULN, n (%) 8 (6.8%) 43 (10.8%) 0.267
Microvascular invasion, n (%) 29 (24.6%) 144 (36.2%) 0.019
Macrovascular invasion, n (%) 13 (11.0%) 54 (13.6%) 0.469
Histology grade
 < 3 54 (45.8%) 179 (45.0%) 0.964
 >= 3 64 (54.2%) 219 (55.0%)  
Capsule, n (%) 86 (72.9%) 289 (72.6%) 0.954
Tumor number    0.817
 1 74 (62.7%) 232 (58.3%)  
 2 27 (22.9%) 89 (22.4%)  
 3 13 (11.0%) 54 (13.6%)  
 > 3 4 (3.4%) 23 (5.8%)  
Ascites, n (%) 8 (6.8%) 31 (7.8%) 0.716
Alcoholism, n (%) 3 (2.5%) 130 (32.7%) < 0.001
Largest tumor size, cm 5.9 ± 4.3 6.0 ± 5.4 0.715
AFP, ng/mL 25 (< 1 – 286980) 58.4 (1.1 – 685353) 0.023
Albumin, g/L 3.9 ± 0.6 4.0 ± 0.6 0.174
Bilirubin, mg/dL 0.9 ± 0.6 1.2 ± 1.4 0.002
Prothrombin time, sec 11.9 ± 1.4 12.2 ± 1.4 0.051
Creatinine, mg/dL 1.0 ± 1.1 1.2 ± 1.0 0.125
AST, U/L 70.0 ± 84.8 70.0 ± 99.0 0.960
ALT, U/L 53.7 ± 50.5 79.7 ± 125.3 0.001
  1. aULN, upper limit of normal; Values in bold, P < 0.05